A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
Join China-based editors Dexter Yan and Xu as they review some of the key points and trends in their recent coverage of the China biopharma market in this Chinese-language podcast.
在本期中国生物技术播客中，Dexter Yan回顾了他在4月的美国癌症研究协会年会（AACR）举办前和再鼎医药总裁及全球肿瘤研发负责人Rafael Amado的采访。Amado在采访中详细阐述再鼎在AACR展示的两个临床前项目，分别是PD-1/IL-12 双抗和靶向LRRC15的抗体偶联药物（ADC）。
Devices authorized for marketing outside the US. Data derived from Citeline’s Meddevicetracker. Updated weekly.
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
With biotech, “the entire tree of life starts to become accessible to us ethically and sustainably,” says Arcaea CEO Jasmina Aganovic. Her company, launched in October 2021, is developing custom keratin molecules for skin and hair, as well as new UV filter technology, among other innovations to expand formulators’ toolkits, not just replace problematic ingredients.
The cosmetics industry has an “optics” problem, and that is creating other issues, namely a growing body of state legislation to address perceived gaps in federal regulatory oversight.
Ballard Spahr attorney Brendan Collins warned attendees to take Prop 65 violation notices seriously and address them in a timely manner, speaking at the Independent Beauty Association’s 2022 Technical Regulatory Forum.
